Oligometastatic disease
Cancer that has spread to only a few places, which may still be curable by treating each spot.
Usually ≤3-5 metastases. SABR-COMET showed OS benefit of metastasis-directed SBRT; ESTRO/EORTC classification distinguishes synchronous, oligorecurrent, oligoprogressive. PSMA PET expands detection in prostate cancer.
Pages like this
not linked directly; found by shared links- TermBiochemical recurrence (BCR)
Shares PSMA-PET-guided metastasis-directed therapy as a curative strategy in oligorecurrent prostate cancer, When the blood test is positive, hunt for the lesion with sensitive imaging, PSMA PET, Prostate cancer.
- TermPrimary tumour
Shares Systemic versus local therapy, Metastasis, The metastatic cascade.
- PathwayTumour dormancy
Shares Metastasis, Hallmark: activating invasion and metastasis, The metastatic cascade, Organ tropism: seed and soil.
- TermDisseminated tumour cells (DTCs)
Shares Metastasis, Hallmark: activating invasion and metastasis, The metastatic cascade.
- TechnologyWhole-body MRI
Shares When the blood test is positive, hunt for the lesion with sensitive imaging, Organ tropism: seed and soil, Metastasis is understood least and studied last, Prostate cancer.
- TechnologyPalliative radiotherapy
Shares Curative intent vs palliative intent, SBRT / SABR (stereotactic radiotherapy), Prostate cancer.
- TermRECIST
Shares Progressive disease and radiographic progression, A regulatory endpoint for drugs that block spread, not tumours, Biopsy the one lesion that is growing while the others shrink.
- TermBone metastases and skeletal-related events
Shares Stereotactic body radiotherapy (SBRT / SABR), Renal cell carcinoma, Prostate cancer.